Business Context and Reporting Period
This Form 8-K Current Report was filed by Molina Healthcare, Inc. on May 24, 2018, regarding events occurring on May 23, 2018. The filing addresses significant executive leadership changes within the company's finance department, specifically the retirement of the Chief Financial Officer (CFO) and the appointment of a successor.
Key Financial Metrics and Compensation
This filing does not report operational financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it details specific compensation arrangements and financial values associated with executive transitions:
- Outgoing CFO Departure Payment: Joseph W. White will receive a cash payment of $1,500,000 upon retirement.
- Outgoing CFO Forfeiture: Mr. White will forfeit unvested equity awards with an aggregate market value exceeding $7,000,000 as of May 24, 2018.
- Incoming CFO Base Salary: Thomas L. Tran's annual base salary is set at $700,000.
- Incoming CFO Bonus Target: Target bonus is 100% of base salary, with a maximum payout of 200%.
- Sign-On Equity Grant: Mr. Tran will receive restricted stock units valued at $1,200,000 and restricted stock valued at $800,000.
- Severance Provision: In the event of termination without cause, Mr. Tran is entitled to 12 times his monthly base salary.
Material Changes Versus Prior Period
The primary material change reported is the transition of the Chief Financial Officer and Treasurer role:
- Departure: Joseph W. White, who served as CFO and Treasurer and previously as interim CEO, is retiring effective June 4, 2018, with his last day of employment on June 6, 2018.
- Appointment: Thomas L. Tran was appointed as the new CFO and Treasurer effective upon Mr. White's retirement. Mr. Tran brings over 35 years of experience in the healthcare and insurance industry, having previously served as CFO for WellCare Health Plans, Uniprise, and ConnectiCare.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, revenue outlook, or management commentary on market conditions. However, it outlines specific contractual risks and contingencies regarding the new CFO:
- Performance Metrics: Mr. Tran's 2018 bonus is weighted 70% on fiscal year net income and 30% on Compensation Committee discretion.
- Equity Vesting: The sign-on restricted stock units are subject to performance-based vesting tied to cumulative net income for the three-year period ending December 31, 2020.
- Restrictive Covenants: Mr. Tran is subject to a one-year non-competition clause and a two-year non-solicitation clause post-employment.
- Change in Control: Specific severance benefits apply if Mr. Tran is terminated without cause within 24 months following a change of control.
Key Facts for Investor Verification
- Verify the exact effective dates of the CFO transition (June 4, 2018) and the final employment date (June 6, 2018).
- Confirm the forfeiture of over $7,000,000 in unvested equity by the outgoing CFO, Joseph W. White.
- Review the performance conditions for the new CFO's $1,200,000 restricted stock unit grant, specifically the cumulative net income target through 2020.
- Note the total potential cash compensation for the new CFO, including the $700,000 base salary and up to $1,400,000 in annual bonuses.
- Check the attached Offer Letter (Exhibit 10.1) for complete terms regarding the "at-will" employment status and severance calculations.